clemastine
Selected indexed studies
- Clemastine. (, 2012) [PMID:31644019]
- Clemastine. (, 2006) [PMID:30000667]
- Drug repurposing: Clemastine fumarate and neurodegeneration. (Biomed Pharmacother, 2023) [PMID:36370521]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Clemastine. (2012) pubmed
- Clemastine. (2006) pubmed
- Drug repurposing: Clemastine fumarate and neurodegeneration. (2023) pubmed
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. (2017) pubmed
- The potential of repurposing clemastine to promote remyelination. (2025) pubmed
- Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis. (2025) pubmed
- Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury. (2023) pubmed
- Insights on therapeutic potential of clemastine in neurological disorders. (2023) pubmed
- Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1-mediated autophagy. (2025) pubmed
- Clemastine and metformin extend the window of NMDA receptor surface expression in ageing oligodendrocyte precursor cells. (2024) pubmed